Usefulness of 3-Month FVC Changes in Assessing Outcomes of Patients With Idiopathic Pulmonary Fibrosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
American Journal of Respiratory and Critical Care Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Three-Month FVC Change: A Trial Endpoint for IPF Based on Individual Participant Data Meta-Analysis
Am J Respir Crit Care Med 2022 Jan 12;[EPub Ahead of Print], FA Khan, I Stewart, S Moss, L Fabbri, KA Robinson, SR Johnson, RG JenkinsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.